Navigation Links
Expression Genetics, Inc. Announces Successful Completion of Phase,I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer

HUNTSVILLE, Ala., April 16, 2007 /PRNewswire/ -- Expression Genetics, Inc., announced today the completion of a Phase I clinical study evaluating the Company's lead drug candidate, EGEN-001. The study, conducted at The University of Alabama at Birmingham and , evaluated the safety, tolerance, preliminary efficacy, and biological activity of the EGEN-001 in 13 patients with advanced recurrent epithelial ovarian cancer. The product, utilizing the Company's proprietary TheraPlas(R) delivery technology, is composed of interleukin-12 (IL-12) gene expression plasmid formulated with a biocompatible delivery polymer and is designed to increase local concentration of IL-12 protein. IL-12 is a potent anti-cancer cytokine which works by enhancing the body's immune system against cancer and inhibiting tumor blood supply. EGEN-001 for treatment of ovarian cancer has been granted Orphan Drug Status by the FDA.

The Phase I clinical trial was an open-label dose escalation study involving four dose levels of EGEN-001 administered intraperitoneally by four weekly infusions in chemotherapy-resistant advanced stage recurrent ovarian cancer patients. The treatment was well tolerated with no apparent dose- related trends in clinical laboratory, ECG, or vital sign parameters. General observations included abdominal cramping, mild to moderate peritonitis, nausea, and mild elevation of body temperature. These data demonstrate that this IL-12 gene therapeutic is safe for intraperitoneal administration in ovarian cancer patients.

Several clinical and biological parameters were evaluated as secondary endpoints of this study. Tumor burden of patients was monitored during treatment and results show 31% of patients showed stable disease. To date, the overall median survival is over 12.2 months with 7 out of 13 patients still surviving. There appeared to be some trend with respect to clinical benefit in the patients treated with
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Inovio Biomedicals DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results
2. Abraxis BioScience Presents Pre-Clinical Findings That Support Role of SPARC Expression in Cancer and the Role of the Nanoparticle Albumin Bound (nab) Technology Platform in Targeting the Pathway
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:4/27/2015)... , April 27, 2015 BioLife ... developer, manufacturer and marketer of proprietary clinical grade ... and precision thermal shipping products for cells ... the United States Food and Drug Administration has confirmed ... Thawing Media products.  While not an endorsement nor approval ...
(Date:4/26/2015)... -- Cancer experts have reported how a Varian Medical ... area of distributed learning is helping to harness the ... Speakers at a Varian-hosted symposium at the 3 rd ... Barcelona detailed the importance of gaining ... help benefit the next patient. With only ...
(Date:4/24/2015)... BARCELONA , Spanien, 24. ... iCAD, Inc. (Nasdaq: ICAD ), ein ... für Behandlungsabläufe und Strahlentherapie für die Früherkennung ... sofortige Verfügbarkeit des ersten Xoft ® ... ) System ® in Spanien im ...
Breaking Medicine Technology:BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 2BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 3BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 4Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 2Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 3Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 2Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 3Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 4Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 5Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 6
... 2010 Welcome to Consumer Reports ... Consumer Reports, Consumer Reports on Health, and ... safety of prescription and non-prescription drugs (including dietary ... and fitness.   Consumer Reports tests health ...
... 17, 2010 Express Scripts, Inc. (Nasdaq: ... structure in the NorthPark development area — the third ... in North St. Louis County. (Logo: ... from a recent independent study that found Express Scripts ...
Cached Medicine Technology:Consumer Reports Health News 2Consumer Reports Health News 3Consumer Reports Health News 4Consumer Reports Health News 5Express Scripts Announces Plan to Build Fourth Building at Headquarters Campus 2Express Scripts Announces Plan to Build Fourth Building at Headquarters Campus 3
(Date:4/27/2015)... CA (PRWEB) April 27, 2015 Healthpointe ... invasive treatments for nail fungi and infections. Onychomycosis, which ... affect up to 10% of adults in the Western ... and irregularity in thickness. , Healthpointe’s Anaheim ... , a branch dedicated to providing quality skincare products ...
(Date:4/27/2015)... 2015 Texas has saved $433 million ... offenders to providing drug offenders with addiction treatment, according ... April 8th. Several states, including Massachusetts, are considering adopting ... Texas has formed community recovery programs to help redress ... Council of State Governments WA, ID, NE, KS, ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Consumer ... Top Service Providers in their respective sectors for Ottawa. ... this year’s winners; your dedication to superior service has ... across Canada, Consumer Choice Award gathers opinions, perceptions and ... businesses. All winners have gone through a rigorous selection ...
(Date:4/27/2015)... 2015 The Sanford J. Grossman Charitable ... Grossman, PhD, has committed $3 million to establish the ... Inflammatory Bowel Disease at the Icahn School of Medicine ... personalized medicine for treatment of Crohn’s disease, with the ... Crohn’s Disease, a chronic inflammatory disorder of the bowel ...
(Date:4/27/2015)... Viejo, CA (PRWEB) April 27, 2015 ... on top of footage with ProTelestrator from Pixel Film Studios. ... draw a freehand sketch over a moving or still video ... to diagram and analyze sports plays or incoming weather patterns. ... Mode" checkbox and then adjust the frame slider to control ...
Breaking Medicine News(10 mins):Health News:Southern California Healthpointe Clinics Now Treating Nail Fungus 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 3Health News:2015 Ottawa Consumer Choice Award-Winners 2Health News:2015 Ottawa Consumer Choice Award-Winners 3Health News:2015 Ottawa Consumer Choice Award-Winners 4Health News:2015 Ottawa Consumer Choice Award-Winners 5Health News:2015 Ottawa Consumer Choice Award-Winners 6Health News:2015 Ottawa Consumer Choice Award-Winners 7Health News:Sanford J. Grossman Charitable Trust Pledges $3 Million to Create Center at Mount Sinai 2Health News:Sanford J. Grossman Charitable Trust Pledges $3 Million to Create Center at Mount Sinai 3Health News:Pixel Film Studios releases ProTelestrator for Final Cut Pro X. 2
... , HARRISBURG, Pa., Nov. 23 United Concordia ... today launched its newly redesigned Web site, www.unitedconcordia.com ... producers, employers and dentists. , "The site boasts ... all geared toward helping visitors find information quickly ...
... , SAN DIEGO, Nov. 23 Victory Pharma, Inc. ("Victory") ... further extension of Victory,s NAPRELAN franchise. , NAPRELAN Dose Card ... moderate pain and inflammation associated with primary dysmenorrhea ... for patients suffering from rheumatoid arthritis or osteoarthritis who may ...
... starting to have sex, CDC report says , MONDAY, Nov. ... U.S. teenage girls have had a sexually transmitted disease (STD), ... government report shows. , "The high burden of STDs among ... study author Dr. Sami L. Gottlieb, from the division of ...
... System study has found that one out of five Type ... more overweight. Researchers reported that 62.4 percent of U.S. ... are morbidly obese. Among African American adults with Type 2 ... of morbid obesity among people with diabetes is increasing at ...
... ... Agency Honored by Association of Marketing and Communication Professionals , ... Salem, MA (PRWEB) November ... that it has received the 2009 MarCom Gold Award in the design/website homepage ...
... Nurtur Receives Accreditation for Five Population Health Programs ... Institute (PHII), a non-profit 501(c)(3) organization, is pleased to announced ... Accreditation Program, v 1.0 (H-TAP(TM)) after two years of development. ... Farmington, CT is the first organization to receive the H-TAP ...
Cached Medicine News:Health News:United Concordia Dental Redesigns Web Site To Provide Improved Access To Information 2Health News:Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card 2Health News:One in Four Teen Girls Have STDs 2Health News:One in Four Teen Girls Have STDs 3Health News:Diabetics show alarming increase in morbid obesity 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 3Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 2Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: